Why a list of drug names is not enough
When an overseas patient sends a summary that says only "R-CHOP" or "chemotherapy," the receiving clinician cannot tell whether the disease shrank, stayed stable, progressed, or returned after a period of control. Each of those situations points to a different review question. A regimen name records what was given; it does not record what the body did in response.
Lymphoma is not one disease. The NCI patient information describes lymphoma as including Hodgkin and non-Hodgkin types, and notes that the exact diagnosis matters when discussing treatment. That distinction is the starting point for any records-based review in China. A diffuse large B-cell lymphoma history and a Hodgkin lymphoma history are not interchangeable, even if some drug names overlap.
For a China review, the useful unit is not "which drugs did I receive" but "what was the diagnosis, what was given, and what happened afterward." That three-part description gives the treating team something to assess. Without it, the review may stall while staff request clarification, which adds time for a patient already managing a serious illness.
The pathology record that anchors the review
The first document to locate is the original pathology report, not a summary letter that mentions lymphoma in passing. The report should identify the subtype as precisely as the local laboratory stated it, and it should note any markers or classification information the pathologist recorded. If the report uses older terminology, keep the original wording rather than translating it into a newer category yourself.
If a biopsy was repeated at relapse or progression, that second report matters too. A receiving team reviewing a possible next step needs to know whether the subtype was confirmed again, and whether any features changed between the first and later samples. Do not discard earlier reports because a newer one exists.
Pathology slides and blocks are separate from the written report. Some hospitals ask to re-examine the original material rather than rely on a transcript. Whether the China hospital wants slides, blocks, or only the report is a question to confirm with that hospital before shipping anything. Do not assume a courier arrangement or a review timeline.
If the original report is unavailable, say so plainly in the enquiry rather than substituting a guess. A clinician can sometimes work from treatment records and imaging, but the limits of the file should be stated, not hidden.
Describing each previous regimen without inventing detail
For every previous line of treatment, the useful facts are the drug names as written in the treatment record, the start and end dates, the number of cycles actually completed, and whether the course finished as planned or stopped early. If a drug was reduced or omitted, note that. If treatment was paused, note when and why, using the reason recorded by the treating team rather than your own interpretation.
Radiotherapy, if given, belongs in the same timeline with the site treated and the dates. Surgery for diagnosis or staging should be listed separately from treatment. A stem cell transplant, if it occurred, is a distinct event with its own date and type; do not fold it into a chemotherapy line.
Avoid converting everything into a single sentence such as "failed two lines." That phrasing hides which regimen was which and what "failed" meant in practice. Write each line as its own short entry so the receiving clinician can see the sequence.
If you are unsure whether a detail belongs, include it with a note that it needs verification against the original record. A flagged uncertainty is more useful than a confident but wrong summary.
- Diagnosis as written, with date and laboratory
- Each regimen: drugs, dates, cycles completed, any reduction or pause
- Radiotherapy: site and dates, if applicable
- Transplant or cellular therapy: type and date, if applicable
- Reason each line ended, in the treating team's words
Response: the part most summaries leave out
Response is what the disease did after treatment, and it is usually documented in imaging reports and clinical notes. For each line, the receiving team wants to know the assessment method used, the date of the assessment, and the conclusion recorded at that time. A PET scan report, a CT report, and a bone marrow report each carry different information; send the reports rather than a paraphrase.
If the record uses a response category such as complete response, partial response, stable disease, or progressive disease, quote the category as written and give the date it was assigned. If no formal category was recorded, describe what the imaging showed in the radiologist's words. Do not upgrade or downgrade the result yourself.
The interval between the end of treatment and any later progression also matters. A response that lasted a long time and a response that ended quickly are different clinical situations, even when the same drugs were used. Record the dates so that interval is visible.
Current status belongs at the end of the timeline: what is known now, when it was last assessed, and what the current treating team has said. If you are between assessments, say that. Do not present an old scan as current.
What the China hospital may ask before it can assess the next step
A records-based review is not the same as confirmed eligibility for a particular treatment. The hospital decides suitability after it sees the file. Your job at the enquiry stage is to make the file clear enough for that decision, and to ask what is still missing.
Ask the receiving hospital, in writing, which documents it needs for a review of the next treatment step, whether it wants original pathology material or accepts reports, whether it needs imaging on disc or in report form, and what language the documents must be in. Ask whether a translation is required and who may provide it. These are hospital-specific questions; do not assume a national rule.
Admission and monitoring needs are also hospital-specific. If the review might lead to treatment in China, ask what the hospital would need to see before discussing an admission plan, and what monitoring it would require. Do not treat an enquiry response as a confirmed bed, appointment date, or treatment start.
If the patient is currently receiving treatment, do not interrupt it for an overseas enquiry. Send records while continuing local care, and let the current team know you are seeking a records-based opinion.
How to send the file and what to expect next
Start with a short summary rather than a complete archive. A useful first message states the subtype, the previous lines with dates, the response after each, the current status, and the specific question you want answered. Attach or offer the key reports: pathology, imaging summaries, and the most recent clinical note. Do not send passport numbers, payment details, or a full medical record at first contact.
After the initial summary, the coordination team can identify what is missing and suggest the relevant next step. An initial enquiry is free and does not require buying a proxy consultation. If a records-based specialist opinion is appropriate, that is a separate, optional step with its own scope; the hospital still decides suitability.
Keep a simple index of what you have sent and when. If a document is unavailable, note that in the index. When the hospital responds with questions, answer them from the record rather than from memory, and correct any earlier summary that turns out to be inaccurate.
The practical goal is a file that lets a lymphoma clinician in China understand the diagnosis, the treatment history, and the response without guessing. That is what makes the next-step discussion possible, and it is the part of the process you can prepare before any decision about travel.
Sources & scope of this guide
References and official service information relevant to this guide.
This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.